Chromocell Therapeutics Corp. (AMEX:CHRO) currently has a daily average trading volume of 87.45K but it saw 1435898 shares traded in last market. With a market cap of 4.44M USD, the company’s current market price of $0.77 came falling about -13.64 while comparing to the previous closing price of $0.89. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.00 and as low as $0.52. In the recent trading on the day, stock has struck highest price mark of $0.68 while lowest mark touched by it was $1.04.
Taking a look at 20-day trading activity of Chromocell Therapeutics Corp. (CHRO) gives us an average price of $0.7183, while its current price level is -87.17% below from 52-week high level whereas it is 47.98% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8008. A closer look into the stock’s movement over the week reveals that its volatility is standing at 27.83% during that period while stretching the period over a month that decreases to 20.37%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.93 which implies that the stock is in neutral territory.
Over the week, CHRO’s stock price is moving 39.91% up while it is -11.64% when we observe its performance for the past one month. Year-to-date it is -83.97% down and over the past year.
Currently, Chromocell Therapeutics Corp.’s total number of outstanding shares is 5.88M. Its return on asset (ROA) is -729.46% on average.
